Citotossicità Cellulo-Mediata Nel Carcinoma Della Vescica

Antonaci S. , Lucivero G. , Piccininno A. , Piccinno A. : Citotossicità spontanea come meccanismo di difesa antineoplastica in soggetti con carcinoma della vescica. Comunicazione preliminare. Folia Allergol. Immunol. Clin., 28; 7 (1981a).

Antonaci S. , Piccinno A. , Lucivero G. , Miglietta A. , Piccininno A. , Bonomo L. : Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment. Tumori, 67; 111 (1981b).

Baldwin R. W. , Embleton M. J. , Jones J. S. P. , Langman J. S. : Cell-mediated and humoral immune reactions to human tumors. Intern. J. Cancer, 12; 73 (1973).

Bean M. , Bloom B. , Herberman R. , Old L. , Oettgen H. , Klein G. , Terry W. : Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res., 35; 2902 (1975).

Billing R. , Terasaki P. I. : Human leukemia antigen. I. Production and characterization of anti-sera. J. Natl. Cancer Inst., 53; 1635 (1974).

Gold P. , Freedman S. O. : Demonstration of tumor-specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med., 121; 439 (1965).

Klein G. , Klein E. : Are methylcholantrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants? Int. J. Cancer, 15; 879 (1975).

Morton D. L. , Malmgren R. A. , Hall W. T. : Immunologic and virus studies with human sarcomas. Surgery, 66; 152 (1969).

Oldham R. K. , Siwarski D. , McCoy J. L. , Plata E. J. , Herberman R. B. : Evaluation of a cell-mediated cytotoxicity assay utilizing ¹²⁵iododeoxyuridine-labeled tissue culture target cells. Natl. Cancer Inst. Monogr., 37; 49 (1973).

Piccinno A. , Antonaci S. , Lucivero G. , Silvestris F. : Correlazione fra citotossicità linfocito-mediata e prognosi nel carcinoma della vescica. Soc. Urol. Centro-Meridionale e delle Isole, Senigallia, 18-20 giugno 1981 (in stampa).

Prehn R. T. , Main J. M. : Immunity to methylcholantrene-induced sarcomas. J. Natl. Cancer Inst., 18; 769 (1957).

Silvestris F. , Antonaci S. , Lucivero G. , Piccinno A. , Bonomo L. : Fenomeni citotossici nel carcinoma della vescica. Linfociti, interazione delle IgG autologhe e significato prognostico. Rec. Progr. Med., 72; 531 (1982).

Tatarinov J. S. : Presence of embryospecific alpha-globulin in the serum of patients with primary hepatocellular carcinoma. Vop. Med. Khim., 10; 90 (1964).

Troye M. , Perlmann P. , Larsson A. , Blomgren H. , Johansson B. : Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: ⁵¹Cr-release assay. Int. J. Cancer, 20; 188 (1977).

Troye M. , Pape G. R. , Paulie S. , Karlsson M. , Perlmann P. , Blomgren H. , Johansson B. : Disease-related in vitro cytotoxicity in patients with transitional cell carcinoma of the urinary bladder. Comparison with other malignancies, acute cystitis and healthy donors. Cancer Immunol. Immunother., 8; 13 (1980 a).

Troye M. , Hannson Y. , Paulie S. , Perlmann P. , Blomgren H. , Johansson B. : Lymphocyte mediated lysis of tumor cells in vitro (ADCC) induced by serum antibodies from patients with urinary bladder carcinoma or controls. Int. J. Cancer, 25; 45 (1980b).

Vilien M. , Wolf H. , Rasmussen F. : Follow-up investigation of bladder cancer patients by titration of natural and specific lymphocyte mediated cytotoxicity. Prognostic significance of specific reactivity, Cancer Immunol. Immunother., 10; 171 (1981).